Systemic mastocytosis

Umaprasanna S. Karnam, Arvey I. Rogers

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Mastocytosis is a disease characterized by an abnormal increase in mast cells. Rare in occurrence, protean in its manifestations, it is a disease which is very seldom thought of and hence, possibly even overlooked. The last few decades have witnessed an upsurge in the understanding of the physiology and pathobiology of mast cells. Better means for diagnosis and follow-up have become available. Once a diagnosis is established histamine antagonists remain the mainstay of treatment. Most patients live and die with the disease rather than of it. The objective of this review is to discuss this entity with a special focus on diagnosis and treatment. Copyright (C) 2000 S. Karger AG, Basel.

Original languageEnglish
Pages (from-to)299-307
Number of pages9
JournalDigestive Diseases
Volume17
Issue number5-6
StatePublished - Dec 1 1999
Externally publishedYes

Fingerprint

Systemic Mastocytosis
Mast Cells
Mastocytosis
Histamine Antagonists
Therapeutics

Keywords

  • Cromolyn
  • Histamine
  • Histamine antagonists
  • Mast cell
  • Mediators
  • PGD
  • Steroids
  • Tryptase
  • Urticaria pigmentosa

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Karnam, U. S., & Rogers, A. I. (1999). Systemic mastocytosis. Digestive Diseases, 17(5-6), 299-307.

Systemic mastocytosis. / Karnam, Umaprasanna S.; Rogers, Arvey I.

In: Digestive Diseases, Vol. 17, No. 5-6, 01.12.1999, p. 299-307.

Research output: Contribution to journalArticle

Karnam, US & Rogers, AI 1999, 'Systemic mastocytosis', Digestive Diseases, vol. 17, no. 5-6, pp. 299-307.
Karnam US, Rogers AI. Systemic mastocytosis. Digestive Diseases. 1999 Dec 1;17(5-6):299-307.
Karnam, Umaprasanna S. ; Rogers, Arvey I. / Systemic mastocytosis. In: Digestive Diseases. 1999 ; Vol. 17, No. 5-6. pp. 299-307.
@article{1d09eaa261de4c77b480657299103c01,
title = "Systemic mastocytosis",
abstract = "Mastocytosis is a disease characterized by an abnormal increase in mast cells. Rare in occurrence, protean in its manifestations, it is a disease which is very seldom thought of and hence, possibly even overlooked. The last few decades have witnessed an upsurge in the understanding of the physiology and pathobiology of mast cells. Better means for diagnosis and follow-up have become available. Once a diagnosis is established histamine antagonists remain the mainstay of treatment. Most patients live and die with the disease rather than of it. The objective of this review is to discuss this entity with a special focus on diagnosis and treatment. Copyright (C) 2000 S. Karger AG, Basel.",
keywords = "Cromolyn, Histamine, Histamine antagonists, Mast cell, Mediators, PGD, Steroids, Tryptase, Urticaria pigmentosa",
author = "Karnam, {Umaprasanna S.} and Rogers, {Arvey I.}",
year = "1999",
month = "12",
day = "1",
language = "English",
volume = "17",
pages = "299--307",
journal = "Digestive Diseases",
issn = "0257-2753",
publisher = "S. Karger AG",
number = "5-6",

}

TY - JOUR

T1 - Systemic mastocytosis

AU - Karnam, Umaprasanna S.

AU - Rogers, Arvey I.

PY - 1999/12/1

Y1 - 1999/12/1

N2 - Mastocytosis is a disease characterized by an abnormal increase in mast cells. Rare in occurrence, protean in its manifestations, it is a disease which is very seldom thought of and hence, possibly even overlooked. The last few decades have witnessed an upsurge in the understanding of the physiology and pathobiology of mast cells. Better means for diagnosis and follow-up have become available. Once a diagnosis is established histamine antagonists remain the mainstay of treatment. Most patients live and die with the disease rather than of it. The objective of this review is to discuss this entity with a special focus on diagnosis and treatment. Copyright (C) 2000 S. Karger AG, Basel.

AB - Mastocytosis is a disease characterized by an abnormal increase in mast cells. Rare in occurrence, protean in its manifestations, it is a disease which is very seldom thought of and hence, possibly even overlooked. The last few decades have witnessed an upsurge in the understanding of the physiology and pathobiology of mast cells. Better means for diagnosis and follow-up have become available. Once a diagnosis is established histamine antagonists remain the mainstay of treatment. Most patients live and die with the disease rather than of it. The objective of this review is to discuss this entity with a special focus on diagnosis and treatment. Copyright (C) 2000 S. Karger AG, Basel.

KW - Cromolyn

KW - Histamine

KW - Histamine antagonists

KW - Mast cell

KW - Mediators

KW - PGD

KW - Steroids

KW - Tryptase

KW - Urticaria pigmentosa

UR - http://www.scopus.com/inward/record.url?scp=0033506024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033506024&partnerID=8YFLogxK

M3 - Article

C2 - 10838487

AN - SCOPUS:0033506024

VL - 17

SP - 299

EP - 307

JO - Digestive Diseases

JF - Digestive Diseases

SN - 0257-2753

IS - 5-6

ER -